The collaboration targets large-volume subcutaneous biologics, aligning a 5.5 mL glass prefillable syringe with an existing autoinjector platform to support higher viscosity drug delivery.

BD presented new delivery technologies and testing services at Pharmapack 2026 to help pharmaceutical and biotech firms address complex biologic formulation challenges.

The BD MAX System automates PCR testing for diverse clinical assays, delivering reliable results in three hours with minimal hands-on time to enhance patient care.

New automation, AI analytics and RFID-based inventory tools debut at ASHP 2025, illustrating how connected technologies can streamline pharmacy workflows and clinical decision-making.

New BD FACSDiscover A8 configurations expand access to advanced spectral and imaging capabilities while offering scalable options for diverse research workflows.

The BD Incada Platform integrates data from millions of connected devices, enabling real-time insights, smarter medication management, and improved efficiency across hospital and pharmacy systems.

The partnership integrates BD’s Rhapsody System with Opentrons’ Flex robots, automating liquid handling and sequencing prep to speed disease research, improve reproducibility, and enable million-cell studies.

The BD Rowa Vmax robotic system will automate high-capacity medication storage, retrieval, and dispensing, providing 24/7 prescription access and freeing pharmacy staff for patient-focused care.

This fully mechanical, patient-ready device supports high-viscosity biologics (up to 50 cP) in 2-10 mL configurations with a simple "peel, stick, click" design.

The Rotarex Atherectomy System is a minimally invasive solution designed to efficiently remove both plaque and thrombus in peripheral arteries.